Targeting immunosuppressive tumor microenvironment to combat immunotherapy resistance: From mechanistic insights to therapeutic strategies
International Immunopharmacology · 2026
DOI: 10.1016/j.intimp.2026.117338 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Immunopharmacology, 2026. Verfasst von Pengfei Su und 5 weiteren Autor:innen. Beteiligte Einrichtung: General Surgery, Cancer Center, Department of Gastrointestinal and Pancreatic Surgery, Zhejiang Provincial People's Hospital, Affiliated People's Hos…. Hauptthemen laut MEDLINE: Tumor Microenvironment, Immunotherapy, Neoplasms. Die Arbeit nennt 352 Literaturangaben. Gefördert von: Science and Technology Program of Zhejiang Province, Department of Education of Zhejiang Province, Natural Science Foundation of Zhejiang Province.
Abstract (Originalsprache)
With advances in deciphering the intricate interplay between tumors and the immune system, tumor immunotherapy has flourished significantly and has revolutionized conventional tumor therapies, owing to its durable immunological memory and favorable safety profile. Nevertheless, immunotherapy is not currently beneficial for all patients, largely due to the immunosuppressive tumor microenvironment (TME). Considerable efforts have been devoted to bolstering the efficacy of immunotherapy by remodeling the TME. Effective remodeling of the TME and the associated reversal of immunosuppressive conditions indicate the potential value of targeting the TME in tumor immunotherapy. Herein, we first elaborate on several mechanisms underlying the formation of immunosuppressive TME based on current evidence and highlight the major obstacles to successful immunotherapy. Subsequently, a variety of strategies concerning remodeling immunosuppressive TME and improving immunotherapeutic efficacy are summarized, and the remaining challenges and future perspectives in the development of antitumor immunotherapy are discussed. Hopefully, the development of immunotherapy will invigorate the further exploration of comprehensive tumor therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- General Surgery, Cancer Center, Department of Gastrointestinal and Pancreatic Surgery, Zhejiang Provincial People's Hospital, Affiliated People's Hospital, Hangzhou Medical College, Hangzhou, Zhejiang 310000, PR China;…
- Department of Gastric Surgery, Fudan University Shanghai Cancer Center, Shanghai 200032, PR China.
- Department of Gastrointestinal Surgery, Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua University, Beijing 102218, PR China.
- General Surgery, Cancer Center, Department of Gastrointestinal and Pancreatic Surgery, Zhejiang Provincial People's Hospital, Affiliated People's Hospital, Hangzhou Medical College, Hangzhou, Zhejiang 310000, PR China.
Förderung
- Science and Technology Program of Zhejiang Province
- Department of Education of Zhejiang Province
- Natural Science Foundation of Zhejiang Province
Zitieren
APA
Su, P., Zhang, Y., Yu, T., Wang, Y., Mou, Y., & Jin, W. (2026). Targeting immunosuppressive tumor microenvironment to combat immunotherapy resistance: From mechanistic insights to therapeutic strategies. International Immunopharmacology. https://doi.org/10.1016/j.intimp.2026.117338
Vancouver
Su P, Zhang Y, Yu T, Wang Y, Mou Y, Jin W. Targeting immunosuppressive tumor microenvironment to combat immunotherapy resistance: From mechanistic insights to therapeutic strategies. International Immunopharmacology. 2026. doi:10.1016/j.intimp.2026.117338
BibTeX
@article{Su2026,
author = {Su, Pengfei and Zhang, Yingjing and Yu, Tian and Wang, Yuanyu and Mou, Yiping and Jin, Weiwei},
title = {Targeting immunosuppressive tumor microenvironment to combat immunotherapy resistance: From mechanistic insights to therapeutic strategies},
journal = {International Immunopharmacology},
year = {2026},
doi = {10.1016/j.intimp.2026.117338}
}
EUVIMED